423 related articles for article (PubMed ID: 34323940)
1. Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.
Arepally GM; Ortel TL
Blood; 2021 Jul; 138(4):293-298. PubMed ID: 34323940
[TBL] [Abstract][Full Text] [Related]
2. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.
Favaloro EJ
Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513
[TBL] [Abstract][Full Text] [Related]
3. Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.
Tarawneh O; Tarawneh H
Am J Hematol; 2021 May; 96(5):E133-E134. PubMed ID: 33476455
[No Abstract] [Full Text] [Related]
4. Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).
Parums DV
Med Sci Monit; 2021 Apr; 27():e932899. PubMed ID: 33900279
[TBL] [Abstract][Full Text] [Related]
5. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
Greinacher A; Selleng K; Mayerle J; Palankar R; Wesche J; Reiche S; Aebischer A; Warkentin TE; Muenchhoff M; Hellmuth JC; Keppler OT; Duerschmied D; Lother A; Rieg S; Gawaz MP; Mueller KAL; Scheer CS; Napp M; Hahnenkamp K; Lucchese G; Vogelgesang A; Flöel A; Lovreglio P; Stufano A; Marschalek R; Thiele T;
Blood; 2021 Oct; 138(14):1269-1277. PubMed ID: 34280256
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
[TBL] [Abstract][Full Text] [Related]
7. COVID-19: Vaccine-induced immune thrombotic thrombocytopenia.
Danish FI; Rabani AE; Subhani FE; Yasmin S; Koul SS
Eur J Haematol; 2022 Dec; 109(6):619-632. PubMed ID: 36030503
[TBL] [Abstract][Full Text] [Related]
8. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways.
Kircheis R
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639132
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management.
Alam W
Sci Prog; 2021; 104(2):368504211025927. PubMed ID: 34120531
[TBL] [Abstract][Full Text] [Related]
10. A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination.
Handtke S; Wolff M; Zaninetti C; Wesche J; Schönborn L; Aurich K; Ulm L; Hübner NO; Becker K; Thiele T; Greinacher A
Blood; 2021 Jul; 137(26):3656-3659. PubMed ID: 33945605
[TBL] [Abstract][Full Text] [Related]
11. Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke.
Kenda J; Lovrič D; Škerget M; Milivojević N
J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106072. PubMed ID: 34461442
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
McGonagle D; De Marco G; Bridgewood C
J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
[TBL] [Abstract][Full Text] [Related]
13. Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT).
Gabarin N; Arnold DM; Nazy I; Warkentin TE
Semin Hematol; 2022 Apr; 59(2):89-96. PubMed ID: 35512906
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia.
Huynh A; Arnold DM; Ivetic N; Clare R; Hadzi-Tosev M; Liu Y; Smith JW; Bissola AL; Daka M; Kelton JG; Nazy I
J Thromb Haemost; 2023 Oct; 21(10):2833-2843. PubMed ID: 37394121
[TBL] [Abstract][Full Text] [Related]
15. Perspectives on vaccine induced thrombotic thrombocytopenia.
Dotan A; Shoenfeld Y
J Autoimmun; 2021 Jul; 121():102663. PubMed ID: 34020254
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategies in FcγIIA receptor-dependent thrombosis and thromboinflammation as seen in heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT).
Müller L; Dabbiru VAS; Schönborn L; Greinacher A
Expert Opin Pharmacother; 2024 Feb; 25(3):281-294. PubMed ID: 38465524
[TBL] [Abstract][Full Text] [Related]
17. Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P's) for anti-PF4 diseases.
Gabarin N; Hack M; Revilla R; Arnold DM; Nazy I
Expert Rev Hematol; 2024; 17(1-3):39-45. PubMed ID: 38149432
[TBL] [Abstract][Full Text] [Related]
18. Vaccine-induced immune thrombotic thrombocytopenia.
Cines DB; Greinacher A
Blood; 2023 Apr; 141(14):1659-1665. PubMed ID: 36669155
[TBL] [Abstract][Full Text] [Related]
19. Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual.
Ogai A; Yoshida R; Yuasa C; Chin K; Fujimaki K; Nakajima H
Int J Hematol; 2022 Feb; 115(2):293-295. PubMed ID: 34716890
[No Abstract] [Full Text] [Related]
20. Prothrombotic immune thrombocytopenia after COVID-19 vaccination.
Tiede A; Sachs UJ; Czwalinna A; Werwitzke S; Bikker R; Krauss JK; Donnerstag F; Weißenborn K; Höglinger G; Maasoumy B; Wedemeyer H; Ganser A
Blood; 2021 Jul; 138(4):350-353. PubMed ID: 34323939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
